14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Predictions

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022
Currently predicting for Fri, 3 May 2024

CBLI Predictions History

4 years ago
brian.rubendall.113111 predicted that CBLI for 2020-02-28 is going

Rank:

4 years ago
JS predicted that CBLI for 2020-02-25 is going $2.43 (6.58%)

4 years ago
Ryan Smith predicted that CBLI for 2020-01-28 is going $4.10 (0.00%)

Rank:

6 years ago
JS predicted that CBLI for 2017-08-03 is going $2.39 (-3.63%)

6 years ago
Victor..Li.8930 predicted that CBLI for 2017-08-03 is going $2.43 (-2.02%)

6 years ago
JS predicted that CBLI for 2017-06-27 is going $3.26 (-2.10%)

6 years ago
JuanC Villegas predicted that CBLI for 2017-06-27 is going $3.37 (1.20%)

6 years ago
JS predicted that CBLI for 2017-06-26 is going $3.46 (2.37%)

6 years ago
JS predicted that CBLI for 2017-06-12 is going $3.40 (-3.13%)

6 years ago
Jon predicted that CBLI for 2017-06-12 is going $3.50 (-0.28%)

Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT